HB940
Enact the Medical Shortage Protection Act
📋 What This Bill Does
HB940, the Medical Shortage Protection Act, aims to prevent price gouging on prescription drugs and related medical supplies during shortages. The bill prohibits suppliers from charging more than 10% above pre-shortage prices and imposes penalties for violations. It also establishes a medical shortage fund to address shortages and allows affected individuals to seek compensatory damages through civil action.
Plain English summary · Non-partisan · Auto-generated
Rationale
The bill partially aligns with libertarian principles by advocating for limited government intervention in the form of prohibiting price gouging during shortages. However, it also introduces price controls, which can distort market mechanisms and hinder free market dynamics.
Risks and Concerns
- Introducing price controls can lead to unintended consequences such as reduced supply, black markets, and inefficiencies in resource allocation.
- Government involvement in setting prices during shortages may discourage innovation and investment in the pharmaceutical industry.
- Price controls can create disincentives for producers to enter or stay in the market, potentially exacerbating shortages in the long run.